Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with second marrow transplants

S E Wright, E D Thomas, C D Buckner

    Experimental Hematology
    |July 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

    Leukemia & lymphoma·2016
    Same author

    Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

    Leukemia & lymphoma·2016
    Same author

    Interleukin-2 in the treatment of hematologic malignancies.

    The cancer journal from Scientific American·2000
    Same author

    Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.

    Blood·2000
    Same author

    Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma.

    The cancer journal from Scientific American·1998
    Same author

    Interleukin-2 in the treatment of hematologic malignancies.

    The cancer journal from Scientific American·1998
    Same journal

    Multidisciplinary Characterization of Rare MPL Y591 and R592 Variants in Myeloid Disorders: From Clinical Correlation and Literature-Based Evidence to In Silico Predictors and Structural Bioinformatics.

    Experimental hematology·2026
    Same journal

    Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALL.

    Experimental hematology·2026
    Same journal

    RNA Binding Protein PCBP1 Functions in the Endothelial-to-Hematopoietic Transition During Hematopoietic Stem Cell Formation.

    Experimental hematology·2026
    Same journal

    Image-enabled cell sorting permits prospective isolation of primitive hematopoietic stem cell subsets with distinct functional potential.

    Experimental hematology·2026
    Same journal

    Inhibition of MLLT1 Limits Growth of KMT2A::AFF1 Leukemias Without Killing Healthy Hematopoietic Stem Cells.

    Experimental hematology·2026
    Same journal

    Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction.

    Experimental hematology·2026
    See all related articles

    Second marrow transplants offer hope for aplastic anemia patients, with successful engraftment achieved after specific conditioning regimens. Hematologic malignancy patients, however, face challenges with disease recurrence post-second transplant despite intensive therapies.

    Area of Science:

    • Hematology
    • Immunology
    • Transplantation

    Background:

    • Second marrow transplantation is a complex procedure for patients experiencing graft failure or disease recurrence after initial therapy.
    • Understanding outcomes is crucial for optimizing patient management and treatment strategies.

    Purpose of the Study:

    • To summarize the clinical experience and outcomes of 25 patients undergoing a second marrow transplant.
    • To evaluate the efficacy of different conditioning regimens and identify factors influencing success.

    Main Methods:

    • Retrospective analysis of 25 patients who received a second marrow transplant.
    • Donors included identical twins, matched siblings, and other matched siblings.
    • Patients received various pre-transplant conditioning regimens, including procarbazine, antithymocyte globulin (ATG), cyclophosphamide, and total body irradiation.

    Related Experiment Videos

    Main Results:

    • Nine patients with aplastic anemia who rejected their first graft showed improved outcomes with specific conditioning, with four successfully regrafted.
    • Twelve patients with hematologic malignancy experienced disease recurrence post-transplant, with early relapse noted even after intensive chemotherapy.
    • Outcomes varied for patients with graft failure, with some achieving engraftment and others succumbing to infection or disease recurrence.

    Conclusions:

    • Second marrow transplantation can be successful for aplastic anemia patients, particularly with optimized conditioning regimens.
    • Hematologic malignancy patients undergoing second transplants face a high risk of disease recurrence, necessitating further research into more effective strategies.
    • Careful patient selection and tailored conditioning protocols are essential for improving outcomes in second marrow transplantation.